Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
67%(4 trials)

Phase Distribution

Ph phase_3
3
50%
Ph phase_2
3
50%

Phase Distribution

0

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (50.0%)
Phase 33 (50.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_2

Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant

NCT00905424
completedphase_3

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

NCT01436162
completedphase_2

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

NCT01435759
completedphase_2

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

NCT00854100
completedphase_3

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

NCT00095758
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00905424Phase 2

Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant

Completed
NCT01436162Phase 3

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Completed
NCT01435759Phase 2

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Completed
NCT00854100Phase 2

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

Completed
NCT00095758Phase 3

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Completed
NCT00095823Phase 3

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6